N-(Phosphonacetyl)-L-aspartate (PALA): current status
- PMID: 7444151
- DOI: 10.1007/978-3-642-81488-4_10
N-(Phosphonacetyl)-L-aspartate (PALA): current status
Abstract
N-(Phosphonoacetyl)-L-aspartate (PALA) is a synthetic antimetabolite exhibiting striking oncolytic properties against a wide variety of experimental solid tumors. The clinical dose-limiting factor is mucocutaneous toxicity which is reversible and dose-related. Delineation of the single-agent activity of PALA in human cancer must still await results of recently activated trials.